Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/15/2007CA2651019A1 Uses of dpp iv inhibitors
11/15/2007CA2650980A1 Statins for the treatment of viral influenza infections
11/15/2007CA2650976A1 Bicyclic heteroaryl compounds as pde10 inhibitors
11/15/2007CA2650970A1 P38 map kinase inhibitors
11/15/2007CA2650954A1 Bicyclic derivatives as cetp inhibitors
11/15/2007CA2650926A1 N1,n4-bis(buta-1,3-dienyl)butane-1,4-diamine pharmaceutical compositions and methods thereof
11/15/2007CA2650853A1 Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms
11/15/2007CA2650825A1 Topical co-enzyme q10 formulations and treatment of pain, fatigue and wounds
11/15/2007CA2650553A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial
11/15/2007CA2650423A1 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and paracetamol
11/15/2007CA2650303A1 Thienopyrimidine pharmaceutical compounds and their use
11/15/2007CA2650286A1 Methods of diagnosis and treatment of equine laminitis and cushing' s syndrome
11/15/2007CA2650255A1 Mglur5 modulators v
11/15/2007CA2650114A1 Mglur5 modulators i
11/15/2007CA2649946A1 New sterilized parenteral formulation
11/15/2007CA2649938A1 Use of flibanserin for the treatment of post-menopausal sexual desire disorders
11/15/2007CA2649917A1 Muscarinic agonists to treat impulse control disorders
11/15/2007CA2649894A1 The use of a glucocorticoid receptor ii antagonist to treat depression in patients taking il-2
11/15/2007CA2649882A1 Novel pharmaceutical compositions
11/15/2007CA2649876A1 Short interfering ribonucleic acid (sirna) for oral administration
11/15/2007CA2649813A1 A system for wireless transmission of measurement results intended to be used in a coupling device and a use of the system in a vehicle
11/15/2007CA2649792A1 Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
11/15/2007CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/15/2007CA2649627A1 Methods and compositions for remediation of disc herniation by modifying structure
11/15/2007CA2649479A1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives
11/15/2007CA2649459A1 Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol and an nsaid
11/15/2007CA2648947A1 Therapy targeting cathepsin s
11/15/2007CA2648831A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
11/15/2007CA2646128A1 Pyrido [2, 3-b] pyrazine and [1, 8] -naphthyridine derivatives as alk and c-met inhibitors
11/15/2007CA2645638A1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
11/15/2007CA2642647A1 Compositions and methods for treatment of disorders of protein aggregation
11/15/2007CA2641100A1 Bicyclic tetrahydropyrrole compounds
11/15/2007CA2640806A1 Bicyclic tetrahydropyrrole compounds
11/15/2007CA2621264A1 Parathyroid hormone analogues and methods of use
11/15/2007CA2618646A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/14/2007EP1854884A2 Immunosuppression by blocking T cell co-stimulation signal 2 (B7/CD28 interaction)
11/14/2007EP1854880A1 Methods and reagents for modulating cholesterol levels
11/14/2007EP1854826A1 Anion-binding polymers and uses thereof
11/14/2007EP1854813A1 High-molecular fucoidan, method of producing the same and cosmetic composition
11/14/2007EP1854800A1 Antitumoral derivatives of Ecteinascidin ET-743
11/14/2007EP1854799A1 Process for the preparation of a taxane derivative
11/14/2007EP1854798A2 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
11/14/2007EP1854795A1 Salt of proline derivative, solvate thereof, and production method thereof
11/14/2007EP1854794A1 2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
11/14/2007EP1854793A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY
11/14/2007EP1854790A1 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function
11/14/2007EP1854787A1 Novel cyclic compound having quinolylalkylthio group
11/14/2007EP1854785A1 4-[(3-fluorophenoxy)phenylmethyl]piperidine methanesulfonate: uses, process of synthesis and pharmaceutical compositions
11/14/2007EP1854784A1 Activator for peroxisome proliferator activating receptor
11/14/2007EP1854780A1 Method of producing chlorogenic acid composition
11/14/2007EP1854777A1 Hydroquinone long-chain derivative and/or phenoxy long-chain derivative, and pharmaceutical preparation comprising the same
11/14/2007EP1854509A2 Methods and compositions for restoring conformational stability of a protein of the p53 family
11/14/2007EP1854486A2 Utilisation of neurotransmitter derivatives for manufacturing agents for treating neuroendocrinal diseases
11/14/2007EP1854485A1 Preventives/remedies for cancer
11/14/2007EP1854484A1 Pain remedy containing rock inhibitor
11/14/2007EP1854483A1 Agent for control of function of antigen-presenting cell
11/14/2007EP1854482A1 Agent for control of degranulation reaction and cytokine production
11/14/2007EP1854473A1 Preventive/therapeutic agent for cancer
11/14/2007EP1854466A1 Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
11/14/2007EP1854465A1 Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
11/14/2007EP1854464A2 Combinations comprising epothilone derivatives
11/14/2007EP1854463A1 Release-control composition
11/14/2007EP1854462A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
11/14/2007EP1854461A1 Prophylactic antistress agent
11/14/2007EP1854460A1 External plaster containing flurbiprofen
11/14/2007EP1854458A1 Use of a compound with RANKL activity
11/14/2007EP1854454A2 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
11/14/2007EP1854453A1 Aqueous composition with shelf life stability comprising a magnesium compound and L-carnitine
11/14/2007EP1854446A1 Antiallergic composition
11/14/2007EP1853619A1 Novel c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity
11/14/2007EP1853618A1 Tricyclic-nucleoside compounds for treating viral infections
11/14/2007EP1853617A1 Tricyclic-nucleoside prodrugs for treating viral infections
11/14/2007EP1853615A1 Novel derivatives of phosphinic amino acids, preparation method thereof and pharmaceutical compositions containing same
11/14/2007EP1853612A1 Purification of rapamycin
11/14/2007EP1853610A1 N-phenyl benzamide derivatives as sirtuin modulators
11/14/2007EP1853609A1 Thienopyridine derivatives and use thereof as hsp90 modulators
11/14/2007EP1853606A1 Pyridopyrazolopyrimidine compounds and their uses as anti-cancer and anti-diabete drugs
11/14/2007EP1853604A2 Chemical compounds
11/14/2007EP1853602A1 Chemical compounds
11/14/2007EP1853601A1 Non steroidal glucocorticoid receptor modulators
11/14/2007EP1853600A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
11/14/2007EP1853599A1 Novel polymorph of mutilin
11/14/2007EP1853597A1 Benzoxazole carboxamides for treating cinv and ibs-d
11/14/2007EP1853596A1 Novel, long-acting betamimetics for treating respiratory diseases
11/14/2007EP1853595A1 (1,5-diphenyl-1h-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics
11/14/2007EP1853594A2 Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
11/14/2007EP1853593A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride
11/14/2007EP1853590A1 Fused heterocyclic compounds and their use as sirtuin modulators
11/14/2007EP1853588A1 Chemical compounds
11/14/2007EP1853587A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
11/14/2007EP1853586A1 Antibacterial piperidine derivatives
11/14/2007EP1853585A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
11/14/2007EP1853584A1 Pyrazole derivatives for the inhibition of cdk's and gsk's
11/14/2007EP1853583A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/14/2007EP1853582A2 Heterocyclylamide-substituted imidazoles
11/14/2007EP1853581A1 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors
11/14/2007EP1853580A1 Methylphenylcarbamic acid 5-(4-isobutyl-2,6,-dioxopiperazin-1-yl)pyridinyl-2-yl ester and salts as hormone sensitive lipase inhibitors
11/14/2007EP1853579A2 2-substituted 5-membered heteroaryl carboxylates as hm74a receptor agonists
11/14/2007EP1853576A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
11/14/2007EP1853575A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
1 ... 3503 3504 3505 3506 3507 3508 3509 3510 3511 3512 3513 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 ... 7860